Dexcom Inc’s recent filing unveils that its EVP Strategy and Corporate Dev Dolan Matthew Vincent unloaded Company’s shares for reported $0.27 million on Apr 15 ’24. In the deal valued at $137.81 per share,1,990 shares were sold. As a result of this transaction, Dolan Matthew Vincent now holds 42,377 shares worth roughly $5.57 million.
Then, SAYER KEVIN R sold 49,633 shares, generating $6,864,136 in total proceeds. Upon selling the shares at $138.30, the President CEO and Chairman now owns 283,893 shares.
Before that, Brown Michael Jon sold 2,624 shares. Dexcom Inc shares valued at $367,472 were divested by the EVP Chief Legal Officer at a price of $140.04 per share. As a result of the transaction, Brown Michael Jon now holds 68,682 shares, worth roughly $9.03 million.
RBC Capital Mkts initiated its Dexcom Inc [DXCM] rating to an Outperform in a research note published on March 12, 2024; the price target was $165. Raymond James also remained covering DXCM and has increased its forecast on April 17, 2023 with a “Strong buy” recommendation from previously “an Outperform” rating. UBS started covering the stock on March 29, 2023. It rated DXCM as “a Buy”.
Price Performance Review of DXCM
On Monday, Dexcom Inc [NASDAQ:DXCM] saw its stock jump 0.62% to $131.52. Over the last five days, the stock has lost -2.26%. Dexcom Inc shares have risen nearly 5.99% since the year began. Nevertheless, the stocks have risen 7.64% over the past one year. While a 52-week high of $142.00 was reached on 03/26/24, a 52-week low of $74.75 was recorded on 02/28/24. SMA at 50 days reached $129.48, while 200 days put it at $115.03. A total of 2.11 million shares were traded, compared to the trading of 2.12 million shares in the previous session.
Levels Of Support And Resistance For DXCM Stock
The 24-hour chart illustrates a support level at 130.05, which if violated will result in even more drops to 128.59. On the upside, there is a resistance level at 132.67. A further resistance level may holdings at 133.83. The Relative Strength Index (RSI) on the 14-day chart is 44.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.67%. Stochastics %K at 18.44% indicates the stock is a buying.
The most recent change occurred on January 26, 2023 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $121 price target.
